Literature DB >> 29311735

Test and Treat H. Pylori Eradication in Dyspepsia-"A Bridge too Far" in the Concensus?

Wojciech Marlicz1, Karolina Skonieczna-Zydecka2, Igor Łoniewski2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29311735     DOI： 10.1038/ajg.2017.280

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

Review 1.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

2.  Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.

Authors:  V P Y Tan; K S H Liu; F Y F Lam; I F N Hung; M F Yuen; W K Leung
Journal:  Aliment Pharmacol Ther       Date:  2017-01-23       Impact factor: 8.171

3.  Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia.

Authors:  Hanne Vanheel; Maria Vicario; Tim Vanuytsel; Lukas Van Oudenhove; Cristina Martinez; Åsa V Keita; Nicolas Pardon; Javier Santos; Johan D Söderholm; Jan Tack; Ricard Farré
Journal:  Gut       Date:  2013-03-08       Impact factor: 23.059

Review 4.  Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis.

Authors:  Li-Jun Du; Bin-Rui Chen; John J Kim; Sarah Kim; Jin-Hua Shen; Ning Dai
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 5.  Kyoto global consensus report on Helicobacter pylori gastritis.

Authors:  Kentaro Sugano; Jan Tack; Ernst J Kuipers; David Y Graham; Emad M El-Omar; Soichiro Miura; Ken Haruma; Masahiro Asaka; Naomi Uemura; Peter Malfertheiner
Journal:  Gut       Date:  2015-07-17       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.